advisorsecurities master

ACHVAchieve Life Sciences, Inc.

CSNasdaq (XNAS)·USD

Identity

Security key
11240
Ticker
ACHV
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
1995-10-12
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ACHV

Detail

Enriched 2026-08-14 20:47

Market cap
$686,789,091.33
Shares outstanding (class)
102,659,057
Shares outstanding (weighted)
102,659,057
SIC
2835 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Employees
28
Location
SEATTLE, WA
Description

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data